Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.55 |
| ▸ | BRPF1 | P55201 | 2/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29755944 | 0.98 | PRKCI (0.57) | PRKCIBRPF1KCNH2BIRC5ALDH1A1 | |
| SCHEMBL16862053 | 0.89 | BIRC5 (0.59) | PRKCIBRPF1KCNH2BIRC5ALDH1A1 | |
| SCHEMBL30364829 | 0.89 | KCNH2 (0.60) | PRKCIBRPF1KCNH2BIRC5ALDH1A1 | |
| SCHEMBL4572982 | 0.89 | KCNH2 (0.60) | PRKCIBRPF1KCNH2BIRC5ALDH1A1 | |
| SCHEMBL14513875 | 0.89 | PRKCI (0.53) | PRKCIBRPF1KCNH2BIRC5ALDH1A1 | |
| SCHEMBL15712437 | 0.89 | SMN1; SMN2 (0.55) | PRKCIBRPF1KCNH2BIRC5ALDH1A1 | |
| SCHEMBL16862145 | 0.86 | KCNH2 (0.54) | PRKCIBRPF1KCNH2BIRC5ALDH1A1 | |
| SCHEMBL30241476 | 0.86 | KCNH2 (0.54) | PRKCIBRPF1KCNH2BIRC5ALDH1A1 | |
| SCHEMBL31735405 | 0.85 | PRKCI (0.49) | PRKCIBRPF1KCNH2MAPTFGFR1 | |
| SCHEMBL720541 | 0.85 | PRKCI (0.49) | PRKCIBRPF1KCNH2MAPTFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3125033-B1 | LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2021-06-02 | — | — | EP | disclosed |
| US-10968392-B2 | Liquid crystal aligning agent for photoalignment, liquid crystal alignment film and liquid crystal display device using it, and diamine and polymer | JNC CORPORATION (JP) | 2021-04-06 | — | — | US | disclosed |
| US-20200332193-A1 | LIQUID CRYSTAL ELEMENT USED FOR PHASE CONTROL OF ELECTROMAGNETIC WAVE SIGNAL | JNC CORPORATION (JP) | 2020-10-22 | — | — | US | disclosed |
| US-10782566-B2 | Liquid crystal display device | JNC CORPORATION (JP) | 2020-09-22 | — | — | US | disclosed |
| EP-3179303-B1 | LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2020-04-01 | — | — | EP | disclosed |
| CN-105367560-B | Tetracarboxylic dianhydride, polymer, aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display element containing triazole | 捷恩智株式会社 | 2019-11-05 | — | — | CN | disclosed |
| US-10435627-B2 | Liquid crystal display device | JNC CORPORATION (JP) | 2019-10-08 | — | — | US | disclosed |
| EP-3133136-B1 | LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2019-08-07 | — | — | EP | disclosed |
| EP-3163368-B1 | LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2019-06-26 | — | — | EP | disclosed |
| US-20190127643-A1 | LIQUID CRYSTAL ALIGNING AGENT FOR PHOTOALIGNMENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING IT, AND DIAMINE AND POLYMER | JNC CORPORATION (JP) | 2019-05-02 | — | — | US | disclosed |
| US-20150105503-A1 | LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME | JNC PETROCHEMICAL CORPORATION (JP) | 2015-04-16 | — | — | US | disclosed |
| US-20150105503-A1 | LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME | JNC PETROCHEMICAL CORPORATION (JP) | 2015-04-16 | — | — | US | disclosed |
| CN-104058993-A | Photosensitive Diamines, Polyamide Acid And Derivatives Thereof, Liquid Crystal Aligning Agents, Liquid Crystal Alignment Films And Liquid Crystal Display Devices | JNC PETROCHEMICAL CORP | 2014-09-24 | — | — | CN | disclosed |
| US-20140243324-A1 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2014-08-28 | — | — | US | disclosed |
| WO-2013161569-A1 | LIQUID-CRYSTAL-ORIENTING AGENT FOR FORMING LIQUID-CRYSTAL-ORIENTED FILM FOR PHOTOALIGNMENT, LIQUID-CRYSTAL-ORIENTED FILM, AND LIQUID-CRYSTAL DISPLAY ELEMENT USING LIQUID-CRYSTAL-ORIENTED FILM | JNC株式会社 (JP) | 2013-10-31 | — | — | WO | disclosed |
| CN-103282034-A | Use of hematopoietic growth factor mimetics | LIGAND PHARM INC | 2013-09-04 | — | — | CN | disclosed |
| CN-103180294-A | Diamine, polyimide precursor, polyimide, liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element | NISSAN CHEMICAL IND LTD | 2013-06-26 | — | — | CN | disclosed |
| US-20120295904-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | LIGAND PHARMACEUTICALS INC. (US) | 2012-11-22 | — | — | US | disclosed |
| CN-102656141-A | Hematopoietic growth factor mimetic small molecule compounds and their uses | LIGAND PHARM INC | 2012-09-05 | — | — | CN | disclosed |
| WO-2012029763-A1 | DIAMINE, POLYIMIDE PRECURSOR, POLYIMIDE, LIQUID-CRYSTAL ALIGNMENT MATERIAL, LIQUID-CRYSTAL ALIGNMENT FILM, AND LIQUID-CRYSTAL DISPLAY ELEMENT | 日産化学工業株式会社 (JP) | 2012-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10968392-B2 | Liquid crystal aligning agent for photoalignment, liquid crystal alignment film and liquid crystal display device using it, and diamine and polymer | DDT, DCLRE1A, DVL1 | PRKCI 1660/4885BRPF1 3465/4885KCNH2 3072/4885 |
| US-20140243324-A1 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | HGF, EPOR, MPL | PRKCI 2155/4885BRPF1 418/4885KCNH2 4861/4885 |
| US-20120295904-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | MPL, CSF3R, HGF | PRKCI 2706/4885BRPF1 957/4885KCNH2 4762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.